These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 37213711)

  • 61. Analysis of Y chromosome haplogroups in Parkinson's disease.
    Grenn FP; Makarious MB; Bandres-Ciga S; Iwaki H; Singleton AB; Nalls MA; Blauwendraat C;
    Brain Commun; 2022; 4(6):fcac277. PubMed ID: 36387750
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MEX-PD: A National Network for the Epidemiological & Genetic Research of Parkinson's Disease.
    Lázaro-Figueroa A; Reyes-Pérez P; Morelos-Figaredo E; Guerra-Galicia CM; Estrada-Bellmann I; Salinas-Barboza K; Matuk-Pérez Y; Gandarilla-Martínez NA; Caballero-Sánchez U; Flores-Ocampo V; Montés-Alcántara P; Espinosa-Méndez IM; Moral AZ; Gaspar-Martínez E; Vazquez-Guevara D; Rodríguez-Violante M; Inca-Martinez M; Mata IF; Alcauter S; Rentería ME; Medina-Rivera A; Ruiz-Contreras AE
    medRxiv; 2023 Aug; ():. PubMed ID: 37693616
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Traditional Chinese Exercise for Neurodegenerative Diseases: A Bibliometric and Visualized Analysis With Future Directions.
    Jiang B; Feng C; Hu H; George D; Huang T; Li Z
    Front Aging Neurosci; 2022; 14():932924. PubMed ID: 35832067
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An analysis of genetic studies of Parkinson's disease in Africa.
    Okubadejo NU
    Parkinsonism Relat Disord; 2008; 14(3):177-82. PubMed ID: 17881276
    [TBL] [Abstract][Full Text] [Related]  

  • 65. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
    Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
    BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.
    Nalls MA; Blauwendraat C; Vallerga CL; Heilbron K; Bandres-Ciga S; Chang D; Tan M; Kia DA; Noyce AJ; Xue A; Bras J; Young E; von Coelln R; Simón-Sánchez J; Schulte C; Sharma M; Krohn L; Pihlstrøm L; Siitonen A; Iwaki H; Leonard H; Faghri F; Gibbs JR; Hernandez DG; Scholz SW; Botia JA; Martinez M; Corvol JC; Lesage S; Jankovic J; Shulman LM; Sutherland M; Tienari P; Majamaa K; Toft M; Andreassen OA; Bangale T; Brice A; Yang J; Gan-Or Z; Gasser T; Heutink P; Shulman JM; Wood NW; Hinds DA; Hardy JA; Morris HR; Gratten J; Visscher PM; Graham RR; Singleton AB; ; ;
    Lancet Neurol; 2019 Dec; 18(12):1091-1102. PubMed ID: 31701892
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genome-wide contribution of common short-tandem repeats to Parkinson's disease genetic risk.
    Bustos BI; Billingsley K; Blauwendraat C; Gibbs JR; Gan-Or Z; Krainc D; Singleton AB; Lubbe SJ;
    Brain; 2023 Jan; 146(1):65-74. PubMed ID: 36347471
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Genetic Modifiers of Age at Onset for Parkinson's Disease in Asians: A Genome-Wide Association Study.
    Li C; Ou R; Chen Y; Gu X; Wei Q; Cao B; Zhang L; Hou Y; Liu K; Chen X; Song W; Zhao B; Wu Y; Li T; Dong X; Shang H
    Mov Disord; 2021 Sep; 36(9):2077-2084. PubMed ID: 33884653
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Does Ethnicity Influence Recruitment into Clinical Trials of Parkinson's Disease?
    Lau YH; Podlewska A; Ocloo J; Gupta A; Gonde C; Bloem BR; Chaudhuri KR
    J Parkinsons Dis; 2022; 12(3):975-981. PubMed ID: 35068418
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A tangled web - tau and sporadic Parkinson's disease.
    Wray S; Lewis PA
    Front Psychiatry; 2010; 1():150. PubMed ID: 21423457
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Peripheral inflammatory cytokines and motor symptoms in persons with Parkinson's disease.
    Diaz K; Kohut ML; Russell DW; Stegemöller EL
    Brain Behav Immun Health; 2022 May; 21():100442. PubMed ID: 35308082
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Precision Medicine in Parkinson's Disease: From Genetic Risk Signals to Personalized Therapy.
    Straccia G; Colucci F; Eleopra R; Cilia R
    Brain Sci; 2022 Sep; 12(10):. PubMed ID: 36291241
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Readiness for Parkinson's disease genetic testing and counseling in patients and their relatives in urban settings in the Dominican Republic.
    Hackl M; Cook L; Wetherill L; Walsh LE; Delk P; De León R; Carbonell J; Vicioso RC; Hodges PD
    NPJ Parkinsons Dis; 2023 Aug; 9(1):126. PubMed ID: 37644148
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Progress toward an integrated understanding of Parkinson's disease.
    Rousseaux MWC; Shulman JM; Jankovic J
    F1000Res; 2017; 6():1121. PubMed ID: 28751973
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Parkinson's Disease and Its Dermatological Associations: Is Your Skin Whispering You a Diagnosis?
    Shah P; Sagar PR; Alhumaidi N; Bollampally VC; Malik BH
    Cureus; 2020 Aug; 12(8):e9933. PubMed ID: 32968594
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Defining the causes of sporadic Parkinson's disease in the global Parkinson's genetics program (GP2).
    Towns C; Richer M; Jasaityte S; Stafford EJ; Joubert J; Antar T; Martinez-Carrasco A; Makarious MB; Casey B; Vitale D; Levine K; Leonard H; Pantazis CB; Screven LA; Hernandez DG; Wegel CE; Solle J; Nalls MA; Blauwendraat C; Singleton AB; Tan MMX; Iwaki H; Morris HR;
    NPJ Parkinsons Dis; 2023 Sep; 9(1):131. PubMed ID: 37699923
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Person-centered home-based rehabilitation for persons with Parkinson's disease: A scoping review.
    Vaartio-Rajalin H; Rauhala A; Fagerström L
    Int J Nurs Stud; 2019 Nov; 99():103395. PubMed ID: 31525645
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease.
    Monfrini E; Di Fonzo A
    Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mitochondrial dysfunction-targeting therapeutics of natural products in Parkinson's disease.
    He T; Lin X; Su A; Zhang Y; Xing Z; Mi L; Wei T; Li Z; Wu W
    Front Pharmacol; 2023; 14():1117337. PubMed ID: 37234707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.